Home › MediciNova to Present Data on MN-001 (tipelukast) for the Treatment...
 

Keywords :   


MediciNova to Present Data on MN-001 (tipelukast) for the Treatment...

2014-09-02 04:24:52| Biotech - Topix.net

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today announced that it will present at the 18th International Colloquium on Lung and Airway Fibrosis to be held this September in Mont Tremblant, Quebec, Canada.

Tags: the data present treatment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »